Molecular Docking and in vitro-Anti-Inflammatory evaluation of Novel Isochromen-1-one Analogues Frometodolac Napoleon Ayyakannu Arumugam*, Sharma Vijay Pharmaceutical Chemistry Laboratory SAS, VIT University, Vellore-632014, Tamil Nadu, India *Corresponding Author E-mail: aanapoleon@vit.ac.in, napoleonaa@gmail.com
Online published on 16 May, 2018. Abstract In the present work, the three synthesizedisochromen-1-one, their thio and N-methylated analogues derived from the anti-inflammatory drug Etodolacare assessed for its in-vitro anti-inflammatory activity and carried out molecular docking studies. Docking study result shows that compound, 5 possess good binding affinity with the COX-1 receptor showing a docking score of-8.2 and lipophilic interaction of-2.5 which is greater when compared to standard drugs such as Etodolac, Aceclofenac and Diclofenac were used. The same compound 5 also shows comparable in-vitroanti-inflammatory activity with etodolac as standard in both the methods screened. Top Keywords Molecular docking, Isochromen-1-one, Etodolac, Isochromen-1-oneanalogues, Antiinflammatory activity. Top |